{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T08:28:32Z","timestamp":1772699312338,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007179","name":"University of New Mexico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009148","name":"Queen Mary University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009148","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ajog.2023.09.100","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T20:19:33Z","timestamp":1696623573000},"page":"243.e1-243.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3229-5846","authenticated-orcid":false,"given":"Cosette M.","family":"Wheeler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norah E.","family":"Torrez-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Torres-Chavolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Parvu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey C.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruofei","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Joste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Cuzick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Joste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosette M.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles L.","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Waxman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Jenison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Howe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicki","family":"Benard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Melkonian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie","family":"Saslow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Stoler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Cuzick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca B.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice L.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salina","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"English","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.09.100_bib1","first-page":"255","article-title":"Human papillomaviruses","volume":"100B","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"10.1016\/j.ajog.2023.09.100_bib2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.09.100_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/CMR.00013-15","article-title":"Human papillomavirus laboratory testing: the changing paradigm","volume":"29","author":"Burd","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ajog.2023.09.100_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.ajog.2023.09.100_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/LGT.0000000000000573","article-title":"Human papillomavirus same genotype persistence and risk: a systematic review","volume":"25","author":"Bonde","year":"2021","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ajog.2023.09.100_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/jnci\/djr283","article-title":"Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical\u00a0cancer","volume":"103","author":"Chen","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2023.09.100_bib7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/jcp.2004.022863","article-title":"Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study","volume":"58","author":"Cuschieri","year":"2005","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.ajog.2023.09.100_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/aje\/kwn036","article-title":"Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis","volume":"168","author":"Koshiol","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2023.09.100_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/CEJ.0b013e328324061a","article-title":"A\u00a07.5-year prospective study of longer than 18 months type-specific human papillomavirus persistence in a routine cytology-based cervical screening population of about 31,000 women in\u00a0West Germany","volume":"18","author":"Kov\u00e1cs","year":"2009","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ajog.2023.09.100_bib10","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/sj.bjc.6604972","article-title":"Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women","volume":"100","author":"Mu\u00f1oz","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2023.09.100_bib11","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1080\/21645515.2015.1088616","article-title":"Persistent infection with human papillomavirus 16 or 18 is\u00a0strongly linked with high-grade cervical disease","volume":"12","author":"Radley","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ajog.2023.09.100_bib12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/v10120729","article-title":"Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing","volume":"10","author":"Chrysostomou","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.ajog.2023.09.100_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jnci\/djx225","article-title":"Relative performance of HPV and cytology components of cotesting in cervical screening","volume":"110","author":"Schiffman","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2023.09.100_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2018.10400","article-title":"Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and\u00a0systematic review for the US Preventive Services Task Force","volume":"320","author":"Melnikow","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.09.100_bib15","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s11606-016-3772-5","article-title":"Cost-effectiveness of primary HPV testing, cytology and co-testing as cervical cancer screening for women above age 30 years","volume":"31","author":"Jin","year":"2016","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.ajog.2023.09.100_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2023.09.100_bib17","unstructured":"BD. Onclarity\u2122 HPV Assay [package insert]. Sparks, MD: Becton, Dickinson and Company;\u00a02018."},{"key":"10.1016\/j.ajog.2023.09.100_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/14737159.2021.1894132","article-title":"Evaluation of the Onclarity\u2122 HPV assay on the high-throughput COR system","volume":"21","author":"Taylor","year":"2021","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.ajog.2023.09.100_bib19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2018.04.007","article-title":"The Onclarity\u2122 human papillomavirus Trial: design, methods, and baseline results","volume":"149","author":"Stoler","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.09.100_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.27608","article-title":"A\u00a0population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination","volume":"132","author":"Wheeler","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.09.100_bib21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1148\/radiol.2015151516","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"277","author":"Bossuyt","year":"2015","journal-title":"Radiology"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2023.09.100_bib22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ajog.2023.09.100_bib23","series-title":"The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes","author":"Nayar","year":"2015"},{"key":"10.1016\/j.ajog.2023.09.100_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02048-20","article-title":"Analytical and clinical sample performance characteristics of the Onclarity\u2122 assay for the detection of human papillomavirus","volume":"59","author":"Young","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ajog.2023.09.100_bib25","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ijc.28514","article-title":"Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trial","volume":"134","author":"Wright","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.09.100_bib26","series-title":"Statistical analysis with missing data","author":"Little","year":"2002"},{"key":"10.1016\/j.ajog.2023.09.100_bib27","doi-asserted-by":"crossref","unstructured":"Pepe MS. The statistical evaluation of medical tests for classification and prediction. United States of America: Oxford University Press; 2003.","DOI":"10.1093\/oso\/9780198509844.001.0001"},{"key":"10.1016\/j.ajog.2023.09.100_bib28","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/bjc.2013.22","article-title":"Comparing the performance of six human papillomavirus tests in a screening population","volume":"108","author":"Cuzick","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2023.09.100_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ygyno.2015.01.551","article-title":"Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial","volume":"137","author":"Monsonego","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.09.100_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/LGT.0000000000000529","article-title":"Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"Egemen","year":"2020","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ajog.2023.09.100_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2018.12.024","article-title":"Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, \u226525 years of age, with NILM cytology","volume":"153","author":"Stoler","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.09.100_bib32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2019.05.012","article-title":"Risk detection for high-grade cervical disease using Onclarity\u2122 HPV extended genotyping in women, \u226525 years of age, with ASC-US or LSIL cytology","volume":"154","author":"Wright","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.09.100_bib33","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/ijc.30375","article-title":"A\u00a0cohort study of cervical screening using partial HPV typing and cytology triage","volume":"139","author":"Schiffman","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.09.100_bib34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2015.06.040","article-title":"A\u00a0study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results","volume":"138","author":"Schiffman","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.09.100_bib35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ijc.28605","article-title":"The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: a population-based study of opportunistic cervical screening in the United States","volume":"135","author":"Wheeler","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.09.100_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pvr.2016.05.004","article-title":"Need for expanded HPV genotyping for cervical screening","volume":"2","author":"Cuzick","year":"2016","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.ajog.2023.09.100_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/LGT.0000000000000494","article-title":"Clinical utility of human papillomavirus genotyping in cervical cancer screening: a systematic review","volume":"24","author":"Bonde","year":"2020","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ajog.2023.09.100_bib38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JCM.02116-14","article-title":"A\u00a0study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results","volume":"53","author":"Schiffman","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ajog.2023.09.100_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/LGT.0000000000000528","article-title":"2019 ASCCP risk-based management consensus guidelines: methods for risk estimation, recommended management, and validation","volume":"24","author":"Cheung","year":"2020","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ajog.2023.09.100_bib40","unstructured":"US Food and Drug Administration. Use of real-world evidence to support regulatory decision-making for medical devices: guidance for industry and Food and Drug Administration staff;\u00a02017."},{"key":"10.1016\/j.ajog.2023.09.100_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ajcp\/aqy169","article-title":"HPV testing with 16, 18, and 45 genotyping stratifies cancer risk for women with normal cytology","volume":"151","author":"Stoler","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ajog.2023.09.100_bib42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the Athena HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ajog.2023.09.100_bib43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1309\/AJCPGW1V2BBWMOCX","article-title":"The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the Athena HPV study","volume":"137","author":"Stoler","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ajog.2023.09.100_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.09.100_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ajcp\/aqy084","article-title":"Detection of cervical neoplasia by human papillomavirus testing in an atypical squamous cells-undetermined significance population: results of the Becton Dickinson Onclarity\u2122 trial","volume":"151","author":"Wright","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ajog.2023.09.100_bib46","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"Wright","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ajog.2023.09.100_bib47","doi-asserted-by":"crossref","first-page":"278.e1","DOI":"10.1016\/j.ajog.2021.03.047","article-title":"The IMproving Primary Screening and Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase","volume":"225","author":"Safaeian","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.100_bib48","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000381","article-title":"The interpretive variability of cervical biopsies and its relationship to HPV status","volume":"39","author":"Stoler","year":"2015","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823007305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823007305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:44:43Z","timestamp":1757591083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823007305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0002937823007305"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.09.100","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.09.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}